Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".
| Title | Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis". |
| Publication Type | Journal Article |
| Year of Publication | 2019 |
| Authors | Tsivgoulis, G., Palaiodimou L., Katsanos A. H., Voumvourakis K., Hadjigeorgiou G. M., Heliopoulos I., Karapanayiotides T., Papathanasopoulos P., Kilidireas C., & Grigoriadis N. |
| Journal | CNS Drugs |
| Volume | 33 |
| Issue | 3 |
| Pagination | 293-295 |
| Date Published | 2019 03 |
| ISSN | 1179-1934 |
| Keywords | Crotonates, Fingolimod Hydrochloride, Humans, Multiple Sclerosis |
| DOI | 10.1007/s40263-019-00615-5 |
| Alternate Journal | CNS Drugs |
| PubMed ID | 30806966 |
